ARGONAUT THERAPEUTICS LIMITED

Company number 09993166

Date	Type	Description	View / Download
24 May 2024	AD03	Register(s) moved to registered inspection location 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT	(1 page)
24 May 2024	AD02	Register inspection address has been changed to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT	(1 page)
18 Mar 2024	CS01	Confirmation statement made on 7 February 2024 with updates	(4 pages)
26 Sep 2023	AA	Total exemption full accounts made up to 30 June 2023	(8 pages)
15 Mar 2023	MA	Memorandum and Articles of Association	(27 pages)
14 Mar 2023	RESOLUTIONS	Resolutions RES01 ‐ Resolution of adoption of Articles of Association	(1 page)
09 Mar 2023	TM01	Termination of appointment of Simon Kerry as a director on 22 February 2023	(1 page)
09 Mar 2023	TM01	Termination of appointment of Nicholas George Dixon-Clegg as a director on 22 February 2023	(1 page)
09 Mar 2023	AP01	Appointment of Mr William John Robert Fleming as a director on 22 February 2023	(2 pages)
28 Feb 2023	AA01	Current accounting period extended from 28 February 2023 to 30 June 2023	(1 page)
23 Feb 2023	CS01	Confirmation statement made on 7 February 2023 with updates	(4 pages)
23 Feb 2023	CH01	Director's details changed for Prof Nicholas Barrie La Thangue on 23 February 2023	(2 pages)
23 Feb 2023	CH01	Director's details changed for Dr Simon Kerry on 23 February 2023	(2 pages)
30 Jan 2023	PSC05	Change of details for Celleron Therapeutics Holdings Limited as a person with significant control on 26 January 2023	(2 pages)
25 Jan 2023	TM02	Termination of appointment of Douglas Mcdonald as a secretary on 22 December 2022	(1 page)
24 Jan 2023	TM01	Termination of appointment of Chan-Hee Park as a director on 22 December 2022	(1 page)
17 Jan 2023	SH01	Statement of capital following an allotment of shares on 22 December 2022 GBP 5,242.64	(3 pages)
16 Jan 2023	PSC07	Cessation of Oxford Sciences Innovation Plc as a person with significant control on 22 December 2022	(1 page)
16 Jan 2023	PSC02	Notification of Celleron Therapeutics Holdings Limited as a person with significant control on 22 December 2022	(2 pages)
29 Nov 2022	RP04SH01	Second filing of a statement of capital following an allotment of shares on 22 September 2022 GBP 5,044.54	(4 pages)
24 Oct 2022	SH01	Statement of capital following an allotment of shares on 22 September 2022 GBP 5,242.64 ANNOTATION Clarification a second filed SH01 was registered on 29.11.2022.	(4 pages)
19 Oct 2022	SH01	Statement of capital following an allotment of shares on 22 September 2022 GBP 4,774.6	(3 pages)
19 Oct 2022	MA	Memorandum and Articles of Association	(30 pages)
19 Oct 2022	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES13 ‐ Creation of new share class 22/09/2022 RES01 ‐ Resolution of adoption of Articles of Association	(1 page)
06 Oct 2022	TM01	Termination of appointment of Bungkwn Lee as a director on 26 September 2022	(1 page)